Showing results (1-10 of 448) with videos related to
Sort By:
Pageof 45
Current Opinion in Pharmacology|October 10, 2015
Dynamics of T cell responses after strokeDipender Gill, Roland VeltkampNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2016
Clinical Trials of Immunomodulation in Ischemic StrokeRoland Veltkamp, Dipender GillJournal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 20, 2016
Severe Hemorrhagic Transformation after Thrombolysis for Acute Ischemic Stroke Prevents Early Neurological ImprovementDipender Gill, Aravindhan Baheerathan, Adarsh Aravind, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 21, 2017
Temporal Trends in the Levels of Peripherally Circulating Leukocyte Subtypes in the Hours after Ischemic StrokeDipender Gill, Prasanthi Sivakumaran, Adarsh Aravind, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 24, 2016
Trends in C-Reactive Protein Levels Are Associated with Neurological Change Twenty-Four Hours after Thrombolysis for Acute Ischemic StrokeDipender Gill, Prasanthi Sivakumaran, Peter Wilding, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 8, 2016
A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological RecoveryDipender Gill, Thomas Cox, Adarsh Aravind, et al.Stroke|October 26, 2018
Genetically Determined FXI (Factor XI) Levels and Risk of StrokeDipender Gill, Marios K Georgakis, Mike Laffan, et al.Plos Medicine|February 3, 2022
The evolution of mendelian randomization for investigating drug effectsDipender Gill, Stephen BurgessEuropean Journal of Neurology|April 11, 2023
Leveraging genetic predictors of factor XI levels to anticipate results from clinical trialsIyas Daghlas, Dipender GillPageof 45